Web Analytics

3 Latest Announced Rounds

  • $75,000,000
    Series B

    1 Investors

    Defense and Space Manufacturing
    Nov 11th, 2025
  • $6,000,000
    Seed
    Software Development
    Nov 11th, 2025
  • $40,000,000
    Unknown

    1 Investors

    Mental Health Care
    Nov 11th, 2025
$871.61M Raised in 41 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Indapta Therapeutics

start up
United States - Seattle & Houston
  • 18/12/2024
  • Unknown
  • $22,500,000

Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.


Related People

Mark FrohlichFounder

Mark Frohlich United States - Greater Seattle Area

N/A